Charting the possible impact of national guidelines on the management of rheumatoid arthritis

C. Carli, J. F P Bridges, J. Ask, S. Lindblad

Research output: Contribution to journalArticle

Abstract

Objective: To identify temporal trends in the prescription of disease-modifying antirheumatic drugs (DMARDs) in patients with early rheumatoid arthritis (RA). Methods: Using data from the Swedish RA register (n = 2584), we analysed the proportion of RA patients prescribed DMARDs at their first consultation between 1997 and 2001. Statistical process control (SPC) was used to chart and analyse major changes in prescription behaviour, while more traditional time series analysis methods (i.e. regression) were used to corroborate the nature of any trend. Results: The SPC method identified an upward shift in the prescription of DMARDs in July 1998 and a change in the process by October 1998. Time series analysis confirmed an increasing trend in DMARD prescription over the period as a whole and the trend was statistically significant (p≤0.0001). Further analysis showed that the trend was driven by a single shift in the data in July 1998 (p≤0.0095), and once this shift was accounted for, no remaining trends within the periods (i.e. before and after the jump) could be detected (p = 0.5934 and 0.7497, respectively). Conclusion: The formulation and promulgation of Swedish guidelines in 1998 may have influenced the prescription of DMARDs for this patient group. Prospectively analysing data derived from clinical registers in real time using SPC shows promise as a means to evaluate interventions designed to have an impact on a national level.

Original languageEnglish (US)
Pages (from-to)188-193
Number of pages6
JournalScandinavian Journal of Rheumatology
Volume37
Issue number3
DOIs
StatePublished - 2008

Fingerprint

Antirheumatic Agents
Rheumatoid Arthritis
Prescriptions
Guidelines
Drug Prescriptions
Referral and Consultation

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Charting the possible impact of national guidelines on the management of rheumatoid arthritis. / Carli, C.; Bridges, J. F P; Ask, J.; Lindblad, S.

In: Scandinavian Journal of Rheumatology, Vol. 37, No. 3, 2008, p. 188-193.

Research output: Contribution to journalArticle

Carli, C. ; Bridges, J. F P ; Ask, J. ; Lindblad, S. / Charting the possible impact of national guidelines on the management of rheumatoid arthritis. In: Scandinavian Journal of Rheumatology. 2008 ; Vol. 37, No. 3. pp. 188-193.
@article{c8479611a2a840068bc963460885ed59,
title = "Charting the possible impact of national guidelines on the management of rheumatoid arthritis",
abstract = "Objective: To identify temporal trends in the prescription of disease-modifying antirheumatic drugs (DMARDs) in patients with early rheumatoid arthritis (RA). Methods: Using data from the Swedish RA register (n = 2584), we analysed the proportion of RA patients prescribed DMARDs at their first consultation between 1997 and 2001. Statistical process control (SPC) was used to chart and analyse major changes in prescription behaviour, while more traditional time series analysis methods (i.e. regression) were used to corroborate the nature of any trend. Results: The SPC method identified an upward shift in the prescription of DMARDs in July 1998 and a change in the process by October 1998. Time series analysis confirmed an increasing trend in DMARD prescription over the period as a whole and the trend was statistically significant (p≤0.0001). Further analysis showed that the trend was driven by a single shift in the data in July 1998 (p≤0.0095), and once this shift was accounted for, no remaining trends within the periods (i.e. before and after the jump) could be detected (p = 0.5934 and 0.7497, respectively). Conclusion: The formulation and promulgation of Swedish guidelines in 1998 may have influenced the prescription of DMARDs for this patient group. Prospectively analysing data derived from clinical registers in real time using SPC shows promise as a means to evaluate interventions designed to have an impact on a national level.",
author = "C. Carli and Bridges, {J. F P} and J. Ask and S. Lindblad",
year = "2008",
doi = "10.1080/03009740701874436",
language = "English (US)",
volume = "37",
pages = "188--193",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Charting the possible impact of national guidelines on the management of rheumatoid arthritis

AU - Carli, C.

AU - Bridges, J. F P

AU - Ask, J.

AU - Lindblad, S.

PY - 2008

Y1 - 2008

N2 - Objective: To identify temporal trends in the prescription of disease-modifying antirheumatic drugs (DMARDs) in patients with early rheumatoid arthritis (RA). Methods: Using data from the Swedish RA register (n = 2584), we analysed the proportion of RA patients prescribed DMARDs at their first consultation between 1997 and 2001. Statistical process control (SPC) was used to chart and analyse major changes in prescription behaviour, while more traditional time series analysis methods (i.e. regression) were used to corroborate the nature of any trend. Results: The SPC method identified an upward shift in the prescription of DMARDs in July 1998 and a change in the process by October 1998. Time series analysis confirmed an increasing trend in DMARD prescription over the period as a whole and the trend was statistically significant (p≤0.0001). Further analysis showed that the trend was driven by a single shift in the data in July 1998 (p≤0.0095), and once this shift was accounted for, no remaining trends within the periods (i.e. before and after the jump) could be detected (p = 0.5934 and 0.7497, respectively). Conclusion: The formulation and promulgation of Swedish guidelines in 1998 may have influenced the prescription of DMARDs for this patient group. Prospectively analysing data derived from clinical registers in real time using SPC shows promise as a means to evaluate interventions designed to have an impact on a national level.

AB - Objective: To identify temporal trends in the prescription of disease-modifying antirheumatic drugs (DMARDs) in patients with early rheumatoid arthritis (RA). Methods: Using data from the Swedish RA register (n = 2584), we analysed the proportion of RA patients prescribed DMARDs at their first consultation between 1997 and 2001. Statistical process control (SPC) was used to chart and analyse major changes in prescription behaviour, while more traditional time series analysis methods (i.e. regression) were used to corroborate the nature of any trend. Results: The SPC method identified an upward shift in the prescription of DMARDs in July 1998 and a change in the process by October 1998. Time series analysis confirmed an increasing trend in DMARD prescription over the period as a whole and the trend was statistically significant (p≤0.0001). Further analysis showed that the trend was driven by a single shift in the data in July 1998 (p≤0.0095), and once this shift was accounted for, no remaining trends within the periods (i.e. before and after the jump) could be detected (p = 0.5934 and 0.7497, respectively). Conclusion: The formulation and promulgation of Swedish guidelines in 1998 may have influenced the prescription of DMARDs for this patient group. Prospectively analysing data derived from clinical registers in real time using SPC shows promise as a means to evaluate interventions designed to have an impact on a national level.

UR - http://www.scopus.com/inward/record.url?scp=45549107672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549107672&partnerID=8YFLogxK

U2 - 10.1080/03009740701874436

DO - 10.1080/03009740701874436

M3 - Article

C2 - 18465453

AN - SCOPUS:45549107672

VL - 37

SP - 188

EP - 193

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 3

ER -